Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Genentech reports ALLEGORY study meets primary endpoint, secondary endpoints
8h ago
CHRO
Premium
The Fly
FDA moves to accelerate biosimilar development, lower drug costs
4d ago
AZN
BMY
Premium
The Fly
Roche price target raised to CHF 255 from CHF 245 at Morgan Stanley
5d ago
CHRO
Premium
The Fly
Roche receives CE mark for Elecsys Dengue Ag test
5d ago
CHRO
Premium
The Fly
Genentech announces INShore study of Gazyva meets primary endpoint
6d ago
CHRO
Premium
The Fly
Roche assumed with an Underperform at Jefferies
7d ago
CHRO
Premium
The Fly
Rapt Therapeutics initiated with a Buy at Guggenheim
7d ago
CHRO
RAPT
Premium
The Fly
Labcorp to offer Elecsys pTau181 test for Alzheimer’s disease
11d ago
LH
Premium
The Fly
Roche reports 9 month group sales CHF 45.86B vs CHF 44.984B last year
11d ago
CHRO
Premium
The Fly
Roche sees FY25 core EPS growing in high single digit range
11d ago
CHRO
Premium
The Fly
Trump Trade: Trump administration prepares new probe into pharma prices
12d ago
CI
AZN
Premium
The Fly
Trump admin prepares new probe into U.S. pharma prices, FT says
12d ago
CI
AZN
Premium
The Fly
Celcuity price target raised to $95 from $70 at Needham
14d ago
CELC
CHRO
Premium
The Fly
Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’
14d ago
CHRO
OLMA
Premium
The Fly
Genentech announces FDA approval for Gazyva for active lupus nephritis
14d ago
CHRO
Premium
The Fly
Genentech announces results from IMvigor011 study
14d ago
CHRO
Premium
The Fly
Roche announces results from phase III evERA Breast Cancer study
15d ago
CHRO
Premium
The Fly
Genentech’s Phase III evERA data showed giredestrant improved PFS survival
15d ago
CHRO
Premium
The Fly
Genentech presents new Phase 3 data for vamikibart
17d ago
CHRO
Premium
The Fly
Roche reports Phase 3 data for satralizumab in SatraGO-1, SatraGO-2
17d ago
CHRO
Premium
The Fly
Underwhelming Roche data helps Veridian’s position in TED, says Jefferies
17d ago
CHRO
VRDN
Premium
The Fly
CHMP recommends EU approval of Roche’s Gazyva/Gazyvaro for lupus nephritis
17d ago
CHRO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
